Annual FCF
-$69.73 M
+$8.73 M+11.12%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual free cash flow is -$69.73 million, with the most recent change of +$8.73 million (+11.12%) on December 31, 2023.
- During the last 3 years, BOLT annual FCF has fallen by -$19.16 million (-37.89%).
- BOLT annual FCF is now -586.19% below its all-time high of -$10.16 million, reached on December 31, 2018.
Performance
BOLT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$14.01 M
+$2.13 M+13.23%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly free cash flow is -$14.01 million, with the most recent change of +$2.13 million (+13.23%) on September 30, 2024.
- Over the past year, BOLT quarterly FCF has increased by +$2.13 million (+13.23%).
- BOLT quarterly FCF is now -198.72% below its all-time high of -$4.69 million, reached on June 30, 2021.
Performance
BOLT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$61.17 M
+$2.91 M+4.54%
September 30, 2024
Summary
- As of February 8, 2025, BOLT TTM free cash flow is -$61.17 million, with the most recent change of +$2.91 million (+4.54%) on September 30, 2024.
- Over the past year, BOLT TTM FCF has increased by +$2.91 million (+4.54%).
- BOLT TTM FCF is now -511.04% below its all-time high of -$10.01 million, reached on March 31, 2020.
Performance
BOLT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BOLT Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +11.1% | +13.2% | +4.5% |
3 y3 years | -37.9% | +13.2% | +4.5% |
5 y5 years | -586.2% | +13.2% | +4.5% |
BOLT Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -17.4% | +11.1% | at high | +43.8% | -3.0% | +27.4% |
5 y | 5-year | -159.7% | +11.1% | -198.7% | +43.8% | -511.0% | +27.4% |
alltime | all time | -586.2% | +11.1% | -198.7% | +43.8% | -511.0% | +27.4% |
Bolt Biotherapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$14.01 M(-13.2%) | -$61.17 M(-4.5%) |
Jun 2024 | - | -$16.14 M(-3.6%) | -$64.08 M(+1.6%) |
Mar 2024 | - | -$16.75 M(+17.4%) | -$63.08 M(-9.5%) |
Dec 2023 | -$69.73 M(-11.1%) | -$14.27 M(-15.6%) | -$69.73 M(-5.3%) |
Sep 2023 | - | -$16.91 M(+11.7%) | -$73.60 M(+3.8%) |
Jun 2023 | - | -$15.14 M(-35.3%) | -$70.87 M(-7.9%) |
Mar 2023 | - | -$23.40 M(+29.0%) | -$76.94 M(-1.9%) |
Dec 2022 | -$78.46 M | -$18.14 M(+27.8%) | -$78.46 M(-0.3%) |
Sep 2022 | - | -$14.19 M(-33.1%) | -$78.68 M(-6.6%) |
Jun 2022 | - | -$21.22 M(-14.9%) | -$84.23 M(+24.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$24.92 M(+35.8%) | -$67.71 M(+14.0%) |
Dec 2021 | -$59.40 M(+17.5%) | -$18.36 M(-7.0%) | -$59.40 M(+8.3%) |
Sep 2021 | - | -$19.74 M(+321.0%) | -$54.84 M(+12.5%) |
Jun 2021 | - | -$4.69 M(-71.8%) | -$48.76 M(-14.7%) |
Mar 2021 | - | -$16.62 M(+20.5%) | -$57.18 M(+13.1%) |
Dec 2020 | -$50.57 M(+88.3%) | -$13.79 M(+0.9%) | -$50.57 M(+37.5%) |
Sep 2020 | - | -$13.67 M(+4.3%) | -$36.78 M(+59.1%) |
Jun 2020 | - | -$13.11 M(+30.9%) | -$23.12 M(+130.9%) |
Mar 2020 | - | -$10.01 M | -$10.01 M |
Dec 2019 | -$26.85 M(+164.2%) | - | - |
Dec 2018 | -$10.16 M | - | - |
FAQ
- What is Bolt Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual FCF year-on-year change?
- What is Bolt Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly FCF year-on-year change?
- What is Bolt Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics TTM FCF year-on-year change?
What is Bolt Biotherapeutics annual free cash flow?
The current annual FCF of BOLT is -$69.73 M
What is the all time high annual FCF for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual free cash flow is -$10.16 M
What is Bolt Biotherapeutics annual FCF year-on-year change?
Over the past year, BOLT annual free cash flow has changed by +$8.73 M (+11.12%)
What is Bolt Biotherapeutics quarterly free cash flow?
The current quarterly FCF of BOLT is -$14.01 M
What is the all time high quarterly FCF for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly free cash flow is -$4.69 M
What is Bolt Biotherapeutics quarterly FCF year-on-year change?
Over the past year, BOLT quarterly free cash flow has changed by +$2.13 M (+13.23%)
What is Bolt Biotherapeutics TTM free cash flow?
The current TTM FCF of BOLT is -$61.17 M
What is the all time high TTM FCF for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high TTM free cash flow is -$10.01 M
What is Bolt Biotherapeutics TTM FCF year-on-year change?
Over the past year, BOLT TTM free cash flow has changed by +$2.91 M (+4.54%)